Patents by Inventor Neil Moss

Neil Moss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240304319
    Abstract: Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.
    Type: Application
    Filed: May 20, 2024
    Publication date: September 12, 2024
    Inventors: Andrew Attila PAL, Leif N. BOWMAN, Eric COHEN, Basab DATTARAY, Edward DAY, Apurv Ullas KAMATH, Aarthi MAHALINGAM, Dana Denea MINOR, Scott A. MOSS, Neil S. PURI, Eli REIHMAN, Conrad WOODS, Laurie L. BERG, Jorge VALDES
  • Publication number: 20230212123
    Abstract: Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
    Type: Application
    Filed: April 20, 2021
    Publication date: July 6, 2023
    Inventors: Scott D. Larsen, James A. Shayman, Michael William Wilson, Neil Moss
  • Patent number: 11220479
    Abstract: Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: January 11, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Scott D. Larsen, James A. Shayman, Kim Hutchings, Neil Moss, Qin Jiang, Nicholas Mayhew, Emily Freeman, Zohreh Sajjadi Hashemi
  • Publication number: 20210122712
    Abstract: Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 29, 2021
    Inventors: Scott D. Larsen, James A. Shayman, Kim Hutchings, Neil Moss, Qin Jiang, Nicholas Mayhew, Emily Freeman, Zohreh Saijadi Hashemi
  • Patent number: 10849901
    Abstract: Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: December 1, 2020
    Assignees: Navigen, Inc., The University of Utah Research Foundation
    Inventors: Kirill Ostanin, Mark Shenderovich, Ashok Bajji, Christopher L. Cioffi, Neil Moss, Hariprasad Vankayalapati, Dean Li
  • Patent number: 10396869
    Abstract: Methods and apparatus for processing an OFDM MIMO signal in a system having at least two transmitters arranged to transmit an output signal pair that includes operating a series of transformations on a pair of input signals so that each stream of the output signal pair contains decodable information from both streams of the input signal pair.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: August 27, 2019
    Assignee: British Broadcasting Corporation
    Inventors: Peter Neil Moss, Adam Wiewiorka
  • Publication number: 20180115352
    Abstract: Methods and apparatus for processing an OFDM MIMO signal in a system having at least two transmitters arranged to transmit an output signal pair that includes operating a series of transformations on a pair of input signals so that each stream of the output signal pair contains decodable information from both streams of the input signal pair.
    Type: Application
    Filed: December 21, 2017
    Publication date: April 26, 2018
    Inventors: Peter Neil Moss, Adam Wiewiorka
  • Publication number: 20170189405
    Abstract: Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.
    Type: Application
    Filed: May 27, 2015
    Publication date: July 6, 2017
    Applicants: Navigen, Inc., The University of Utah Research Foundation
    Inventors: Kirill Ostanin, Mark Shenderovich, Ashok Bajji, Christopher L. Cioffi, Neil Moss, Hariprasad Vankayalapati, Dean Li
  • Publication number: 20160065277
    Abstract: A method of deriving a precoding matrix for a MIMO signal operates by maximising a function of channel capacity over values of precoding matrices so as to maximise the minimum channel capacity for the set of channel realisations. In this way, the least worst channel capacity may be achieved in broadcast arrangements in which the actual channel may be unknown.
    Type: Application
    Filed: May 13, 2014
    Publication date: March 3, 2016
    Inventors: Peter Neil Moss, Adam Wiewiorka
  • Patent number: 9187828
    Abstract: A coating is formed by chemical vapor deposition an electrically heated filament which is passed through an end plate into a deposition chamber and leaves the deposition chamber through a similar end plate. The filament slides through an entrance passage into the deposition chamber. The entrance passage is formed from misaligned portions which press the filament into direct electrical contact with their walls. A tube communicates with a chamber between the ends of the passage and acts as a sealing means to prevent gas escaping from the deposition chamber through the entrance passage. The end plate operates in exactly the same manner. As no mercury or a low-melting point eutectic alloy is used, no contaminants associated therewith are produced and the resultant coated filament is free of such contaminants.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: November 17, 2015
    Assignee: Tisics Limited
    Inventors: Ray Paul Durman, Robert Alan Shatwell, Stephen John Kyle-Henney, Renny Neil Moss, Robert Slightam
  • Patent number: 8609696
    Abstract: Disclosed are Serotonin 5-HT2B receptor inhibitors of the formula I. Also disclosed are methods of making and methods of using these compounds.
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: December 17, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Derek Cogan, Neil Moss, Christopher Ronald Sarko, Samantha Jayne Bamford, Pui Leng Loke, Heather Tye, Mark Whittaker
  • Patent number: 8562242
    Abstract: A spline structure, in the form of an aeronautical brake drive bar, has wheel attachment points at its ends for engaging a wheel rim. Each wheel carries a regularly spaced series of these drive bars for engaging friction discs carried by the wheel hub. The main body of each brake drive bar is formed from titanium internally reinforced by composite blocks each comprising a bundle of silicon carbide fibers contained in a matrix that is diffusion bonded within the main body. Other spline structures can be formed in a similar manner.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: October 22, 2013
    Assignee: Tisics Limited
    Inventors: David Philip Murgatroyd, Stephen Mark Flitcroft, Renny Neil Moss, Stephen John Kyle-Henney
  • Patent number: 8552205
    Abstract: Derivatives of 6,7-dihydro-5H-imidazo[1,2-?]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: October 8, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Antonio Jose del Moral Barbosa, Jr., Joerg Martin Bentzien, Steven Richard Brunette, Zhidong Chen, Derek Cogan, Donghong A. Gao, Alexander Heim-Riether, Joshua Courtney Horan, Jennifer A. Kowalski, Michael David Lawlor, Rene Marc Lemieux, Weimin Liu, Bryan McKibben, Craig Andrew Miller, Neil Moss, Matt Aaron Tschantz, Zhaoming Xiong, Hui Yu, Yang Yu
  • Publication number: 20110269742
    Abstract: Disclosed are Serotonin 5-HT2B receptor inhibitors of the formula I. Also disclosed are methods of making and methods of using these compounds.
    Type: Application
    Filed: December 14, 2009
    Publication date: November 3, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Derek Cogan, Neil Moss, Christopher Ronald Sarko, Samantha Jayne Bamford, Pui Leng Loke, Spencer Charles R. Napier, Heather Tye, Mark Whittaker
  • Publication number: 20110224188
    Abstract: Derivatives of 6,7-dihydro-5H-imidazo[1,2-?]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
    Type: Application
    Filed: November 20, 2008
    Publication date: September 15, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Antonio Jose del Moral Barbosa, Joerg Martin Benzien, Steven Richard Brunette, Zhidong Chen, Derek Cogan, Donghong A. Gao, Alexander Heim-Riether, Joshua Courtney Horan, Jennifer A. Kowalski, Michael David Lawlor, Rene Marc Lemieux, Weimin Liu, Bryan Mckibben, Craig Andrew Miller, Neil Moss, Matt Aaron Tschantz, Zhaoming Xiong, Hui Yu, Yang Yu
  • Patent number: 7790712
    Abstract: The application relates to compounds of formula Ia and analogues thereof wherein R1 to R13 and X are as defined herein. The invention also relates to the use of the compounds of formula Ia as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: September 7, 2010
    Assignee: Boehringer Ingelheim Pharmaceutical, Inc.
    Inventors: Derek Cogan, Donghong A. Gao, Daniel R. Goldberg, Craig Andrew Miller, Neil Moss, Matthew Russell Netherton, Philip Dean Ramsden, Zhaoming Xiong
  • Publication number: 20100190773
    Abstract: Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.
    Type: Application
    Filed: March 19, 2010
    Publication date: July 29, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Asitha ABEYWARDANE, Craig Andrew MILLER, Tina Marie MORWICK, Neil MOSS, Matthew Russell NETHERTON, Roger John SNOW, Ji WANG, Jiang-Ping WU, Zhaoming XIONG
  • Publication number: 20100047574
    Abstract: A coating is formed by chemical vapour deposition an electrically heated filament which is passed through an end plate into a deposition chamber and leaves the deposition chamber through a similar end plate. The filament slides through an entrance passage into the deposition chamber. The entrance passage is formed from misaligned portions which press the filament into direct electrical contact with their walls. A tube communicates with a chamber between the ends of the passage and acts as a sealing means to prevent gas escaping from the deposition chamber through the entrance passage. The end plate operates in exactly the same manner. As no mercury or a low-melting point eutectic alloy is used, no contaminants associated therewith are produced and the resultant coated filament is free of such contaminants.
    Type: Application
    Filed: August 29, 2008
    Publication date: February 25, 2010
    Inventors: Ray Paul Durman, Robert Alan Shatwell, Stephen John Kyle-Henney, Renny Neil Moss, Robert Slightam
  • Publication number: 20100047475
    Abstract: A coating is formed by chemical vapour deposition an electrically heated filament which is passed through an end plate into a deposition chamber and leaves the deposition chamber through a similar end plate. The filament slides through an entrance passage into a first electrode chamber, around part of a wheel electrode into the deposition chamber. The passage of the filament around the wheel electrode provides adequate direct electrical contact. The end plate operates in exactly the same manner. As no mercury or a low-melting point eutectic alloy is used, no contaminants associated therewith are produced and the resultant coated filament is free of such contaminants.
    Type: Application
    Filed: August 29, 2008
    Publication date: February 25, 2010
    Inventors: Ray Paul Durman, Robert Alan Shatwell, Stephen John Kyle-Henney, Renny Neil Moss, Robert Slightam
  • Publication number: 20100014913
    Abstract: A spline structure, in the form of an aeronautical brake drive bar, has wheel attachment points at its ends for engaging a wheel rim. Each wheel carries a regularly spaced series of these drive bars for engaging friction discs carried by the wheel hub. The main body of each brake drive bar is formed from titanium internally reinforced by composite blocks each comprising a bundle of silicon carbide fibres contained in a matrix that is diffusion bonded within the main body. Other spline structures can be formed in a similar manner.
    Type: Application
    Filed: May 31, 2007
    Publication date: January 21, 2010
    Applicant: TISICS LIMITED
    Inventors: David Philip Murgatroyd, Stephen Mark Flitcroft, Renny Neil Moss, Stephen John Kyle-Henney